Canada markets open in 8 hours 50 minutes

  • S&P/TSX
    18,299.62
    +239.36(+1.33%)

  • S&P 500
    3,901.82
    +90.67(+2.38%)

  • DOW
    31,535.51
    +603.14(+1.95%)

Sire Bioscience Inc. (BLLXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2352-0.0198 (-7.76%)
At close: 3:27PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-09-30
2019-03-31
2018-03-31
2017-03-31
Total Revenue
125
0
125
50
0.116
Operating Expenses
Research Development
37.316
-
52.259
85.999
0.985
Selling General and Administrative
1,318
1,563
1,828
284.974
142.025
Total Operating Expenses
1,355
1,563
1,881
370.973
143.01
Operating Income or Loss
-1,230
-1,563
-1,756
-320.973
-142.894
Interest Expense
-
679.297
-
-
-
Total Other Income/Expenses Net
-71.8
-4,157
-131.1
41.876
0
Income Before Tax
-1,298
-6,396
-1,884
-276.213
-141.72
Income from Continuing Operations
-1,298
-6,396
-1,884
-276.213
-141.72
Net Income
-1,298
-6,396
-1,884
-276.213
-141.72
Net Income available to common shareholders
-1,298
-6,396
-1,884
-276.213
-141.72
Basic EPS
-
-0.40
-0.20
-0.10
-0.07
Diluted EPS
-
-0.40
-0.20
-0.10
-0.07
Basic Average Shares
-
14,434
10,826
4,441
3,035
Diluted Average Shares
-
14,434
10,826
4,441
3,035
EBITDA
-
-5,717
-1,756
-320.973
-142.894